These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1058672)

  • 1. Extensive drug surveillance--a pilot study.
    Gerke DC; Easterbrook EG; Frewin DB; Lee TI
    Aust N Z J Med; 1975 Aug; 5(4):336-40. PubMed ID: 1058672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intense surveillance of adverse drug reactions. An analysis of 338 patients.
    Vakil BJ; Kulkarni RD; Chabria NL; Chadha DR; Deshpande VA
    J Clin Pharmacol; 1975; 15(5-6):435-41. PubMed ID: 1133220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication prescribing on a university medical service-the incidence of drug combinations with potential adverse interactions.
    Simborg DW
    Johns Hopkins Med J; 1976 Jul; 139(1):23-6. PubMed ID: 948149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of 10% in the Rate of Adverse Drug Reactions for Each Drug Administered in Hospitalized Patients.
    Ribeiro MR; Motta AA; Marcondes-Fonseca LA; Kalil-Filho J; Giavina-Bianchi P
    Clinics (Sao Paulo); 2018; 73():e185. PubMed ID: 29451619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial.
    O'Connor MN; O'Sullivan D; Gallagher PF; Eustace J; Byrne S; O'Mahony D
    J Am Geriatr Soc; 2016 Aug; 64(8):1558-66. PubMed ID: 27365262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between number of drugs and duration of hospital stay in older patients with neuromuscular diseases.
    Nishida S; Hayashi Y; Suzuki A; Kobayashi R; Inuzuka T; Itoh Y
    Geriatr Gerontol Int; 2018 Jul; 18(7):1018-1024. PubMed ID: 29512265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?
    Carbonin P; Pahor M; Bernabei R; Sgadari A
    J Am Geriatr Soc; 1991 Nov; 39(11):1093-9. PubMed ID: 1753048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: a study protocol.
    Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P
    BMJ Open; 2016 Oct; 6(10):e011811. PubMed ID: 27797997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic integrated approach to improvement of drug prescribing in an acute care hospital: a potential model for applied hospital pharmacoepidemiology.
    Strom BL; Gibson GA
    Clin Pharmacol Ther; 1993 Aug; 54(2):126-33. PubMed ID: 8354021
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia.
    Dedefo MG; Mitike AH; Angamo MT
    BMC Pediatr; 2016 Jul; 16():81. PubMed ID: 27387547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
    Haffner S; von Laue N; Wirth S; Thürmann PA
    Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized survelliance of adverse drug reactions in hospital: pilot study.
    Azaz-Livshits T; Levy M; Sadan B; Shalit M; Geisslinger G; Brune K
    Br J Clin Pharmacol; 1998 Mar; 45(3):309-14. PubMed ID: 10896407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.
    Dormann H; Muth-Selbach U; Krebs S; Criegee-Rieck M; Tegeder I; Schneider HT; Hahn EG; Levy M; Brune K; Geisslinger G
    Drug Saf; 2000 Feb; 22(2):161-8. PubMed ID: 10672897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group.
    Emerson A; Martin RM; Tomlin M; Mann RD
    Pharmacoepidemiol Drug Saf; 2001; 10(2):95-103. PubMed ID: 11499859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective research study of anti-glaucoma drugs prescribing, utilization pattern and adverse drug reaction recording in a university hospital.
    Alaei M; Najmi AK; Kausar H; Akhtar M
    Drug Res (Stuttg); 2015 Mar; 65(3):164-8. PubMed ID: 24871930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events in hospitalized elderly.
    Gray SL; Sager M; Lestico MR; Jalaluddin M
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M59-63. PubMed ID: 9467435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.